Hatice Nida Sen

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Primary intraocular lymphoma: diagnosis and differential diagnosis
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Ocul Immunol Inflamm 17:133-41. 2009
  2. pmc Rifabutin-associated hypopyon uveitis and retinal vasculitis with a history of acute myeloid leukemia
    Wendy M Smith
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Dr, Building 10, Rm 10N112, Bethesda, MD, 20892, USA
    J Ophthalmic Inflamm Infect 2:149-52. 2012
  3. doi request reprint Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases
    Breno R Lima
    National Eye Institute, National Institutes of Health, Laboratory of Immunology, Bethesda, MD 20892, USA
    Expert Opin Drug Metab Toxicol 9:875-82. 2013
  4. pmc A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient
    Wendy M Smith
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Dr, 10 10N112, Bethesda, MD, 20892, USA
    J Ophthalmic Inflamm Infect 3:37. 2013
  5. pmc Subconjunctival sirolimus for the treatment of chronic active anterior uveitis: results of a pilot trial
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Am J Ophthalmol 153:1038-42. 2012
  6. pmc Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ocul Immunol Inflamm 20:104-12. 2012
  7. pmc Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration
    Baoying Liu
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Transl Med 9:1-12. 2011
  8. pmc A standardized grading system for scleritis
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 118:768-71. 2011
  9. pmc High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis
    H Nida Sen
    National Eye Institute, NIH, Bethesda, MD 20892, USA
    Am J Ophthalmol 148:696-703.e1. 2009
  10. ncbi request reprint Subclinical inflammation after laser in situ keratomileusis in corneal grafts
    Hatice Nida Sen
    Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    J Cataract Refract Surg 28:782-7. 2002

Collaborators

Detail Information

Publications28

  1. pmc Primary intraocular lymphoma: diagnosis and differential diagnosis
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Ocul Immunol Inflamm 17:133-41. 2009
    ..In addition to cytology, flow cytometry, immunohistochemistry, molecular analysis and cytokines may be used as adjuncts in facilitating the diagnosis...
  2. pmc Rifabutin-associated hypopyon uveitis and retinal vasculitis with a history of acute myeloid leukemia
    Wendy M Smith
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Dr, Building 10, Rm 10N112, Bethesda, MD, 20892, USA
    J Ophthalmic Inflamm Infect 2:149-52. 2012
    ..This study reports a case of bilateral rifabutin-associated uveitis in a child with a history of acute myeloid leukemia...
  3. doi request reprint Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases
    Breno R Lima
    National Eye Institute, National Institutes of Health, Laboratory of Immunology, Bethesda, MD 20892, USA
    Expert Opin Drug Metab Toxicol 9:875-82. 2013
    ..Ocular inflammatory diseases comprise uveitis, scleritis, and inflammation of adjacent structures of the eye. Therapy may be challenging and often involves corticosteroids and immunomodulatory agents...
  4. pmc A rare case of endogenous Aspergillus conicus endophthalmitis in an immunocompromised patient
    Wendy M Smith
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, 10 Center Dr, 10 10N112, Bethesda, MD, 20892, USA
    J Ophthalmic Inflamm Infect 3:37. 2013
    ..He had bilateral anterior uveitis, granulomatous vitritis with a preretinal granuloma in the right eye, and nongranulomatous vitritis with two quadrants of chorioretinal scarring in the left...
  5. pmc Subconjunctival sirolimus for the treatment of chronic active anterior uveitis: results of a pilot trial
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Am J Ophthalmol 153:1038-42. 2012
    ..To evaluate the safety and possible efficacy of subconjunctival sirolimus for the treatment of chronic active anterior uveitis...
  6. pmc Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ocul Immunol Inflamm 20:104-12. 2012
    ..To assess the prevalence of hypotony in patients with severe forms of uveitis...
  7. pmc Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration
    Baoying Liu
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Transl Med 9:1-12. 2011
    ..Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients. Our aim is to study whether C5a can impact human T cells and its implication in AMD...
  8. pmc A standardized grading system for scleritis
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ophthalmology 118:768-71. 2011
    ..This study evaluated the performance of a standardized grading system for scleritis using standard digital photographs...
  9. pmc High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis
    H Nida Sen
    National Eye Institute, NIH, Bethesda, MD 20892, USA
    Am J Ophthalmol 148:696-703.e1. 2009
    ....
  10. ncbi request reprint Subclinical inflammation after laser in situ keratomileusis in corneal grafts
    Hatice Nida Sen
    Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland
    J Cataract Refract Surg 28:782-7. 2002
    ..To evaluate postoperative inflammatory reaction in the eye after laser in situ keratomileusis (LASIK) in corneal grafts...
  11. pmc Infliximab for the treatment of active scleritis
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Can J Ophthalmol 44:e9-e12. 2009
    ..This study aimed to evaluate the possible safety and effectiveness of infliximab in patients with active scleritis...
  12. ncbi request reprint Occult primary carcinoma metastatic to the iris
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Acta Ophthalmol Scand 82:746-7. 2004
  13. ncbi request reprint CMV retinitis in a patient with good syndrome
    H Nida Sen
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Ocul Immunol Inflamm 13:475-8. 2005
    ..To describe cytomegalovirus (CMV) retinitis in a patient with Good syndrome...
  14. ncbi request reprint Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003
    ..These studies suggest that anti-IL-2 receptor blockade could be useful in the treatment of Th1-mediated autoimmune conditions...
  15. pmc Fundus autofluorescence imaging of the white dot syndromes
    Steven Yeh
    National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Ophthalmol 128:46-56. 2010
    ..To characterize the fundus autofluorescence (FAF) findings in patients with white dot syndromes (WDSs)...
  16. pmc High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis
    Steven Yeh
    National Eye Institute, National Institutes of Health, Bethesda, MD, USA
    J Autoimmun 31:91-7. 2008
    ..This study was designed to provide preliminary data regarding the safety and efficacy of high-dose humanized anti-IL-2 receptor (daclizumab) therapy for the treatment of active intermediate, posterior or panuveitis...
  17. ncbi request reprint Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis
    Michael R Robinson
    National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1863, USA
    J Immunother 27:478-9. 2004
    ..This suggests that CTLA-4 is an important regulatory molecule for maintenance of tolerance to melanosomal antigens and prevention of uveitis...
  18. pmc A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularization
    Robert B Nussenblatt
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Retina 30:1579-87. 2010
    ..We compared anti-VEGF therapy plus one of three systemic immunosuppressive therapies versus anti-VEGF therapy alone for recurrent choroidal neovascularization associated with age-related macular degeneration...
  19. pmc Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2
    Chloe Gottlieb
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 1863, USA
    Ophthalmic Genet 31:24-9. 2010
    ..Despite features of T cell dysfunction, infection and autoimmunity (including juvenile idiopathic arthritis), uveitis has not been described in patients with DiGeorge syndrome...
  20. pmc Epidemiology and course of disease in childhood uveitis
    Janine A Smith
    National Eye Institute, National Institutes of Health Department of Health and Human Services, Bethesda, Maryland, USA
    Ophthalmology 116:1544-51, 1551.e1. 2009
    ..To describe the disease characteristics and visual outcome of pediatric uveitis...
  21. pmc Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma
    Dana J Wallace
    Laboratory of Immunology, Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, MD 20895 1857, USA, and Department of Ophthalmology, Tokyo Medical and Dental University, Japan
    Invest Ophthalmol Vis Sci 47:2750-6. 2006
    ..This study examined the expression of the bcl-2 t(14;18) translocation, the bcl-10 gene, and high expression of bcl-6 mRNA in PIOL cells...
  22. pmc Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA
    Ocul Immunol Inflamm 16:29-33. 2008
    ..To describe the clinical course of a patient with multiple recurrences of primary intraocular lymphoma (PIOL)...
  23. ncbi request reprint Mycophenolate mofetil for the treatment of scleritis
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Ophthalmology 110:1750-5. 2003
    ..To evaluate the usefulness of mycophenolate mofetil (MMF) (CellCept, Roche, Nutley, NJ), an antimetabolite immunosuppressant with a selective antiproliferative effect on T and B lymphocytes, for the treatment of scleritis...
  24. pmc Gene expression profiling in autoimmune noninfectious uveitis disease
    Zhuqing Li
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 181:5147-57. 2008
    ..The results may facilitate further understanding of the molecular mechanisms of autoimmune uveitis and other autoimmune originated inflammatory diseases...
  25. pmc A case of rapid progression and vision loss in a patient with primary intraocular lymphoma
    Amit Sangave
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Ocul Immunol Inflamm 18:99-100. 2010
    ..To describe an atypical case of primary intraocular lymphoma (PIOL) with rapid progression leading to vision loss and death...
  26. ncbi request reprint Traumatic cataract and other adverse events with the implantable contact lens
    Anna Ulrika Sarikkola
    Helsinki University Eye Hospital, Helsinki, Finland
    J Cataract Refract Surg 31:511-24. 2005
    ..To evaluate the surgical outcome and adverse events associated with implantation of the implantable contact lens (ICL) for the correction of high myopia or high hyperopia...
  27. ncbi request reprint Waldenström's macroglobulinemia-associated retinopathy
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, Room 10N112, 9000 Rockville Pike, Bethesda, MD 20892 1857, USA
    Ophthalmology 111:535-9. 2004
    ..To report the clinical, electrophysiologic, and immunopathologic findings in a patient with progressive retinal degeneration associated with Waldenström's macroglobulinemia...
  28. pmc 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma
    Steven Yeh
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, 10N 112, 10 Center Drive, Bethesda, MD 20892, USA
    Br J Ophthalmol 94:633-8. 2010
    ..The availability of expert ophthalmic pathological consultation, flow cytometry, cytokine evaluation and gene rearrangement studies were essential to the diagnosis...